Special: No. 1 Stock to Buy Right Now - This New Tech Could Fund Your Retirement

  • Facebook
  • Twitter

Options Profits Daily

Guardant Health, Inc. (Nasdaq: GH), a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, reported financial results for the first quarter ended March 31, 2019. The stock jumped on the news. GlobeNewswire reported, “During...